mCRPC PRO

mCRPC PRO

Charles Ryan, MD summarizes The Lancet article, Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with mCRPC: patient-reported outcome results of a randomised phase 3 trial, from November 2013.

Charles J. Ryan, MD
Professor of Clinical Medicine
Division of Hematology / Oncology
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco

Click HERE to read the abstract

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe